SI-BONEĀ® Ramps to Over 200 Sales Representatives Nationwide and Expands Nationwide Surgeon Training

U.S. training focuses on sacroiliac joint dysfunction diagnostic process and minimally invasive treatment with the iFuse Implant System

Cupertino, California, Oct. 5 -- SI-BONE, Inc. (Cupertino, California) announced today that it has reached a milestone in training spine surgeons and distributors on their iFuse Implant System for minimally invasive treatment of sacroiliac (SI) joint dysfunction.

The company has inked agreements with twelve premier spine surgery equipment distributors to introduce the iFuse for minimally invasive surgical treatment of SI Joint dysfunction. SI Joint dysfunction is often associated with low back pain (LBP), a common malady in the US.

SI-BONE has accelerated its sales and distribution efforts in the last four months, to expand its countrywide sales arm to a total of 222 sales representatives. These distributors represent major markets from California to Texas to New York.

"We expect to have additional agreements in place within the next few weeks, and a significant ramp up in first surgical cases," says Jeffrey Dunn, the CEO of SI-BONE. Additionally, Jeffrey Dunn reports: "We’ve trained over 20 spine surgeons in the last three months and have plans to train an additional 30 surgeons by year end.”

Frank Tedesco, one of the principals at the New York-based distributor, Eclipse Surgical, added, "We're very pleased to be representing SI-BONE and it's minimally invasive device, iFuse, for treatment of SI Joint dysfunction. This is a significant clinical issue and we are in a unique position to promote the iFuse to spine surgeons as an effective minimally invasive treatment for this condition.”

The company has conducted training sessions in many cities in the last few months including Indianapolis, Boston, Minneapolis, Detroit, Atlanta, Los Angeles, Buffalo and has numerous additional training sessions scheduled. Cadaveric Lab trainings are scheduled in October in Las Vegas, New York, Charleston, Denver and San Francisco. Inquiries can be made by calling SI-BONE at 408-725-9070, extension 21.

In response to increasing awareness of SI Joint dysfunction as a debilitating symptom generator, including LBP, SI-BONE, Inc. developed an innovative, patented, intramedullary implant to treat the SI Joint. Surgeons in numerous locations throughout the country are performing iFuse surgery, with one surgeon recently performing three in one day. The company is also planning a post-market multicenter study to determine its effect over time on SI Joint pathology and on symptoms associated with SI Joint dysfunction.

The iFuse Implant System is commercially available device in the US for treatment of pelvic fractures due to sacroiliitis and traumatic disruptions. Having a small incision surgical option to treat an unmet clinical need like SI Joint Dysfunction should prove to be an enormous benefit to both patients and surgeons alike. The iFuse procedure uses a minimal incision and small, titanium implants. The implants are coated with a porous plasma spray that acts as an interference surface, designed to help decrease implant motion. These implants have substantial thickness and sophisticated metallurgy and are able to produce a much stronger construct than that of conventional pins or screws used to surgically fix boney structures. The implant technology from SI-BONE has been previously used successfully in approximately 1,000 cases of dysfunctional foot joints.

About SI-BONE, Inc.
SI-BONE, Inc. (Cupertino, California) is a leading spinal medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to sacroiliac (SI) joint pathology. The company has developed, and is manufacturing and marketing, less invasive implants for SI Joint pathology. SI-BONE has an experienced management team with extensive experience in orthopedic and spine medical devices. The company’s goal is to help surgeons improve lives through its proprietary technology. Please visit www.si-bone.com.

Press Contact

Jeff Polack
Vice President, Marketing
SI-BONE, Inc
408-207-0700
ext. 2212
jeffp@si-bone.com

Meetings & Events that SI-BONE will be attending »